Try our mobile app

Published: 2021-05-19 16:49:01 ET
<<<  go to SGEN company page
8-K
false 0001060736 0001060736 2021-05-14 2021-05-14

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 14, 2021

 

 

Seagen Inc.

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware   0-32405   91-1874389
(State or other jurisdiction of
incorporation or organization)		   (Commission
File Number)		   (I.R.S Employer
Identification No.)

 

21823 30th Drive SE
Bothell, Washington 98021
(Address of principal executive offices, including zip code)

(425) 527-4000

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock, par value $0.001   SGEN   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Shareholders of Seagen Inc. (the “Company”), the Company’s shareholders voted on the three proposals listed below. The final results of the votes regarding each proposal are set forth below. The proposals are described in the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on March 31, 2021 (the “Proxy Statement”).

 

  1.

To elect the following three Class II directors to hold office until the Company’s 2024 Annual Meeting of Shareholders.

 

Name

    Votes For      Votes
Against		      Abstentions      Broker
Non-Votes		  

Felix J. Baker, Ph.D.

      116,400,057        45,221,489        36,628        8,162,921  

Clay B. Siegall, Ph.D.

      157,253,087        3,948,803        456,284        8,162,921  

Nancy A. Simonian, M.D.

      146,459,775        15,144,335        54,064        8,162,921  

 

  2.

To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

 

Votes For

   

Votes Against

   

Abstentions

   

Broker Non-Votes

138,283,308

    23,289,861    85,005    8,162,921

 

  3.

To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.

 

Votes For

   

Votes Against

   

Abstentions

   

Broker Non-Votes

165,999,088

    3,714,145    107,862    —

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    SEAGEN INC.
Date: May 19, 2021     By:  

/s/ Jean I. Liu

      Jean I. Liu
      Executive Vice President, Legal Affairs & General Counsel